Nature Reviews Clinical Oncology

Nature Reviews Clinical Oncology, published by Springer Nature, is a premier monthly peer-reviewed journal dedicated to the advancement of clinical oncology. With a staggering 2026 Impact Factor of 94.600 and consistently ranked in the JCR Q1 quartile, it stands as one of the most authoritative and highly cited periodicals in the field of cancer medicine. The journal’s scope encompasses the full spectrum of clinical oncology, from translational research and early-phase trials to late-stage therapeutic strategies, cancer genetics, immunotherapy, precision medicine, and supportive care. It provides comprehensive, authoritative, and accessible synthesis of the latest developments, helping clinicians and researchers navigate the rapidly evolving landscape of cancer diagnosis and treatment. The journal primarily publishes invited review articles, including authoritative Reviews, Perspectives, and Consensus Statements, alongside incisive News & Views, Research Highlights, and Correspondence. These article types are crafted to distill complex data into actionable insights for a target audience of practicing oncologists, clinical researchers, medical educators, and healthcare policy makers. A notable feature is its rigorous editorial process, which ensures content is both scientifically robust and clinically relevant. While not an open access journal by default, authors may choose to publish open access under a Creative Commons license via the Springer Nature hybrid model. Its exceptional Impact Factor, far exceeding those of most oncology journals, secures its position as an indispensable resource for evidence-based clinical practice and a benchmark for quality in the oncology literature.